Organization
Ocumension Therapeutics
2 clinical trials
Clinical trial
A Phase 3,Prospective, Randomized, Double-masked, Placebo-controlled, Parallel Study to Evaluate the Efficacy, PK and Safety of 9% Dexamethasone Intraocular Injection for the Treatment of Inflammation Associatedwith Cataract SurgeryStatus: Completed, Estimated PCD: 2023-11-24
Clinical trial
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of OT202 Eye Drops in the Treatment of Moderate to Severe Dry EyeStatus: Completed, Estimated PCD: 2024-01-26